Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE American:NBY)

4.35
Delayed Data
As of Sep 18
 +0.35 / +8.75%
Today’s Change
2.25
Today|||52-Week Range
5.09
+31.82%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close4.00
Today’s open4.05
Day’s range4.05 - 4.40
Volume39,500
Average volume (3 months)19,760
Market cap$61.2M
Dividend yield--
Data as of 09/18/2017

Growth & Valuation

Earnings growth (last year)+79.47%
Earnings growth (this year)+68.04%
Earnings growth (next 5 years)--
Revenue growth (last year)+171.56%
P/E ratioNM
Price/Sales2.61
Price/Book8.60

Competitors

 Today’s
change
Today’s
% change
EIGREiger BioPharmaceuti...+0.40+3.59%
SPHSSophiris Bio Inc-0.01-0.34%
RNNRexahn Pharmaceutica...+0.04+1.75%
LIFEaTyr Pharma Inc+0.17+4.73%
Data as of 09/18/2017

Financials

Next reporting dateNovember 10, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$11.9M
Annual profit (last year)-$13.2M
Net profit margin-110.54%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
Chief Financial Officer
Jack J. McGovern
Corporate headquarters
Emeryville, California

Forecasts